1,4-Dihydro-5-(2-propoxyphenyl)-1,2,3-triazolo(4,5-d)pyrimidin-7-one; M and B 22948; 37762-06-4; CAS-37762-06-4; Spectrum3_000933; Zaprinast; KBio2_001745; Spectrum2_001447; Spectrum4_001032; KBio3_001966.
show more »
1,4-Dihydro-5-(2-propoxyphenyl)-1,2,3-triazolo(4,5-d)pyrimidin-7-one; M and B 22948; 37762-06-4; CAS-37762-06-4; Spectrum3_000933; Zaprinast; KBio2_001745; Spectrum2_001447; Spectrum4_001032; KBio3_001966; DivK1c_000584; Spectrum_001265; 2-(o-Propoxyphenyl)-8-azapurin-6-one; 3,6-Dihydro-5-(o-propoxyphenyl)-7H-v-triazolo(4,5-d)pyrimidin-7-one; KBioGR_001583; EU-0101240; KBioSS_001745; M&B 22,948; AIDS059764; 8-Aza-2-(2-propoxyphenyl)-6-purinone; KBio2_004313; M&B 22948; Prestwick_655; Zaprinastum [INN-Latin]; Tocris-0947; 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 1,4-dihydro-5-(2-propoxyphenyl)-; Lopac-Z-0878; SPBio_001313; 2-(2-Propoxyphenyl)-8-aza-6-purinone; 3,6-Dihydro-5-(2-propoxyphenyl)-7H-(1,2,3)truaziki(4,5-d)pyrimidin-7-on; SPBio_002290; NINDS_000584; M&B-22948; EINECS 253-655-1; NCGC00016105-02; NCGC00016105-01; Zaprinast [BAN:INN]; 5-(2-Propoxy-phenyl)-3,6-dihydro-[1,2,3]triazolo[4,5-d]pyrimidin-7-one; AIDS-059764; 55122-20-8; KBio1_000584; 2-o-Propoxyphenyl-8-azapurine-6-one; Prestwick1_000335; KBio2_006881; Prestwick0_000335; NCGC00024894-01
show less «
